Gene and Cell Therapy Therapeutic Mechanisms and Strategies
As with the previous edition, this book covers all aspects of gene and cell therapies from bench to bedside in chapters contributed by authors worldwide. It covers the basic principles of all technologies through to state-of-the-art strategies and applications. The newly updated edition contains add...
| Otros Autores: | |
|---|---|
| Formato: | Electrónico |
| Idioma: | Inglés |
| Publicado: |
Boca Raton, Florida :
CRC Press
2015.
|
| Edición: | 4th ed |
| Materias: | |
| Acceso en línea: | Conectar con la versión electrónica |
| Ver en Universidad de Navarra: | https://innopac.unav.es/record=b31905389*spi |
Tabla de Contenidos:
- Front Cover; Contents; Foreword: Gene and Cell Therapy Matures to the Clinics; Preface; Editor; Contributors; Chapter 1: Lentiviral Vectors : Design and Applications; Chapter 2: Adenovirus-Vector-Mediated Gene Delivery : Barriers and Chemical Vector Modifications; Chapter 3: Helper-Dependent Adenoviral Vectors for Gene Therapy; Chapter 4: Adeno-Associated Virus and AAV Vectors for Gene Delivery; Chapter 5: Vaccinia Viral Vectors for Vaccines and Oncolytic Virotherapy; Chapter 6: Oncolytic Measles Virus-Based Delivery Systems; Chapter 7: Alphavirus Vectors in Gene Therapy and Neuroscience; Chapter 8: Oncolytic Viruses for Treatment of CancerChapter 9: Baculovirus : A High-Capacity Vector for Versatile Gene Transfer; Chapter 10: Baculovirus as a Gene Delivery Vector for Bone and Cartilage Tissue Engineering; Chapter 11: Bacteria as Gene Therapy Vectors for Cancer; Chapter 12: Redox-Responsive Polymer-Based Gene Delivery Systems; Chapter 13: Receptor-Targeted Polyplexes for pDNA and siRNA Delivery; Chapter 14: Dendrimers, Dendrigrafts, and Their Conjugations as Delivery Vectors in Gene Therapy; Chapter 15: Gene Electrotransfer; Chapter 16: Magnetofection : Using Magnetic Particles and Magnetic Force to Enhance and Target Nucleic Acid DeliveryChapter 17: New Advances in Cell-Based Drug and Gene Delivery Systems; Chapter 18: Pressurized Transvenous-Retrograde Extremity Perfusion; Chapter 19: Optimization of Nonviral Gene Therapeutics Using Bilamellar Invaginated Vesicles; Chapter 20: Antisense Oligonucleotide-Based Therapeutics; Chapter 21: Development of RNAi Therapeutics; Chapter 22: Therapeutic Applications of Morpholino Oligonucleotides; Chapter 23: Therapeutic Potential of microRNAs; Chapter 24: Monitoring Gene and Cell Therapies in Living Subjects with Molecular Imaging TechnologiesChapter 25: Deliberate Regulation of Therapeutic Transgenes : Recent Advances in System Development and Uses; Chapter 26: Nonviral Genome Modification Strategies for Gene Therapy : Transposon, Integrase, and Nuclease Systems; Chapter 27: Selectable Markers for Gene Therapy; Chapter 28: Pluripotent Stem Cells and Their Therapeutic Applications; Chapter 29: Adult Lung Stem Cells; Chapter 30: Placenta-Derived Cells and Their Therapeutic Applications; Chapter 31: Directing Pluripotent Human Embryonic Stem Cells toward Lineage-Specific Cell Therapy Derivatives for Regenerative MedicineChapter 32: Surgical and Translational Aspects of Tissue Engineering; Chapter 33: DNA Vaccines; Chapter 34: Cell and Gene Therapies for Cardiovascular Disease; Chapter 35: Gene Therapy for Hematopoietic Disorders; Chapter 36: Update on Preclinical and Clinical Gene Therapy for the Treatment of Cystic Fibrosis; Chapter 37: Gene Therapy for Vision Disorders; Chapter 38: Cell and Gene Therapies for the Treatment of Hearing Disorders; Chapter 39: Molecular Therapy for Type 1 and Type 2 Diabetes.
